Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | KUMAR AND BROTHERS | 1 | ₹2.6 L |
| 2 | Schedule 2 | KUMAR AND BROTHERS | 1 | ₹4,860 |
| 3 | Schedule 3 | VANDANA MEDICO TRADERS | 6 | ₹17,886 |
| 4 | Schedule 4 | VANDANA MEDICO TRADERS | 1 | ₹8,850 |
| 5 | Schedule 5 | VANDANA MEDICO TRADERS | 1 | ₹7,749 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
16 May 2024, 8:00 pmClosed
CHOLINE SALICYLATE 8.7% + LIDOCAINE 2% (DOLOGEL)
CILOSTAZOL 50 MG TAB
CIPROFLOXACIN 250MG TAB
Ciprofloxacin 500mg+ Tinidazole 600mg Tab
E/D Travoprost (0.004% W/v) Bott Of 5 Ml
Ear Drop Chloramphenicol 5% W/v Clotrimazole 1% W/v Betamethasone 0.25% W/v Lignocaine HCl 2% W/v In
EMTRICITABINE 200 MG+ TENOFOVIR 300 MG TAB
ENDOXIFEN 10MG Tab
Enzalutamide 80 Mg Tab
Flupentixol 0.5 Mg Tab
Fluptrine 100mg Tab
FOLEYS CATHETER 2 WAY SIZE 14 FR
FOLEYS CATHETER ALL SIZE
Hydrochlorothiazide 25 Mg Tab
Hydrocortisone 10 Mg Tab
Hydrocortisone 5mg Tab
Imipramine 25 Mg Tab
Indapamide SR 1.5mg Tab
INJ AMIKACIN SULPHATE 250 MG/ML
6305863
GEM/2024/B/4855587
Two Packet Bid
CHOLINE SALICYLATE 8.7% + LIDOCAINE 2% (DOLOGEL),CILOSTAZOL 50 MG TAB,CIPROFLOXACIN 250MG TAB,Cipro
30 days
Punjab; Amritsar
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| CHOLINE SALICYLATE 8.7% + LIDOCAINE 2% (DOLOGEL) | - | - | - |
| CILOSTAZOL 50 MG TAB | - | - | - |
| CIPROFLOXACIN 250MG TAB | - | - | - |
| Ciprofloxacin 500mg+ Tinidazole 600mg Tab | - | - | - |
| E/D Travoprost (0.004% W/v) Bott Of 5 Ml | - | - | - |
| Ear Drop Chloramphenicol 5% W/v Clotrimazole 1% W/v Betamethasone 0.25% W/v Lignocaine HCl 2% W/v In | - | - | - |
| EMTRICITABINE 200 MG+ TENOFOVIR 300 MG TAB | - | - | - |
| ENDOXIFEN 10MG Tab | - | - | - |
| Enzalutamide 80 Mg Tab | - | - | - |
| Flupentixol 0.5 Mg Tab | - | - | - |
| Fluptrine 100mg Tab | - | - | - |
| FOLEYS CATHETER 2 WAY SIZE 14 FR | - | - | - |
| FOLEYS CATHETER ALL SIZE | - | - | - |
| Hydrochlorothiazide 25 Mg Tab | - | - | - |
| Hydrocortisone 10 Mg Tab | - | - | - |
| Hydrocortisone 5mg Tab | - | - | - |
| Imipramine 25 Mg Tab | - | - | - |
| Indapamide SR 1.5mg Tab | - | - | - |
| INJ AMIKACIN SULPHATE 250 MG/ML | - | - | - |
Exempted
16 May 2024
25 Apr 2024
16 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6305863.pdf
GEM_BID
re-31_2024-04-11-10-59-03_d975e446cbb1a0e0a5009f74d18d581f.pdf
SPECIFICATION
re-31_2024-04-11-10-59-46_e95ba8c5d7e9f765fce566c8d695286a.pdf
SPECIFICATION
re-31_2024-04-11-11-00-08_5a06923387fe6b9949ecb94a9a9902f4.pdf
SPECIFICATION
re-31_2024-04-11-11-00-29_e852e5826b606130cfd208fc24fe3cbe.pdf
SPECIFICATION
re-31_2024-04-11-11-00-59_be06d5f717587b74fa6b7e4918d74586.pdf
SPECIFICATION
re-31_2024-04-11-11-01-21_975299661e0385ad3d9812e480d9e373.pdf
SPECIFICATION
re-31_2024-04-11-11-01-43_573066ea19ca4bb49100e69f66f13670.pdf
SPECIFICATION
re-31_2024-04-11-11-02-08_00c61d77933978b2af72c6e86c98ec11.pdf
SPECIFICATION
re-31_2024-04-11-11-02-30_49f4ff3a04553265c19bd741ebf432cd.pdf
SPECIFICATION
re-31_2024-04-11-11-04-13_c5525509eaf7a4614e64fba1834ce84e.pdf
SPECIFICATION
re-31_2024-04-11-11-04-35_518639c15ca6a16a2c16c2f025200ab2.pdf
SPECIFICATION
re-31_2024-04-11-11-06-02_4d5fb7e3b7435b746572205af8ed6e40.pdf
SPECIFICATION
re-31_2024-04-11-11-06-29_7c587893f00d7f06e47dc71a21ab9b6d.pdf
SPECIFICATION
re-31_2024-04-11-11-07-03_6804e38f61741582b542fd9bf4fddb21.pdf
SPECIFICATION
re-31_2024-04-11-11-07-25_b662de691227796329699e238724cf81.pdf
SPECIFICATION
re-31_2024-04-11-11-07-46_95b6e530a75158474e03f11137701d0f.pdf
SPECIFICATION
re-31_2024-04-11-11-08-07_dacaaf2f2312cda738b9c3ea615f21c8.pdf
SPECIFICATION
re-31_2024-04-11-11-08-27_4adf7295ea77bceb91dc91eca4eeb474.pdf
SPECIFICATION
re-31_2024-04-11-11-08-54_bf934472b1cd2ab67851859d358e419a.pdf
SPECIFICATION
re-31_2024-04-11-11-09-16_6ff89dfd0dcdd206691d59501c5393c8.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .